Sanofi India has informed that the unaudited financial results of the Company for the quarter and half year ended 30th June 2021 were approved by the Board of Directors of the Company at its meeting held on 27th July 2021 and published on 29th July 2021. Pursuant to Regulation 23(9) of Listing Regulations, the company has enclosed the disclosures of related party transactions for the half year ended 30th June 2021 in the format specified in the applicable accounting standards.
The above information is a part of company’s filings submitted to BSE.
